文献速递放疗物理与技术

放射治疗计划同行评审是否影响临床诊疗?一项系统综述

Does Peer Review of Radiation Plans Affect Clinical Care? A Systematic Review of the Literature.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-09-20

该系统综述纳入11项研究、共11,491例患者,评估同行评审对放疗计划的影响。同行评审导致加权平均10.8%的放疗计划被修改,其中重大修改和轻微修改的加权平均率分别为1.8%和7.3%。最常见修改涉及靶区勾画(45.2%)、剂量处方或书面医嘱(24.4%)以及非靶区勾画或正常组织保护(7.5%)。

要点

  • 同行评审使约每9例中1例的放疗计划发生修改。
  • 重大修改加权平均率为1.8%,轻微修改为7.3%。
  • 靶区勾画是最常见的修改类型,占修改计划的45.2%。

核心结论

  • 同行评审总体上导致约每9例中1例的放疗计划发生临床诊疗改变。
  • 该修改率与放射科和病理科等其他肿瘤相关专科的同行评审研究报道相似。

研究设计与样本

  • 按照PRISMA指南对MEDLINE和EMBASE数据库及主要放射肿瘤学科学会议摘要进行系统综述。
  • 纳入标准为报告同行评审对至少1项治疗计划要素(如靶区或危及器官勾画、剂量处方或剂量学)影响的研究。
  • 初检识别882项可能合格研究,最终11项符合纳入标准进入全文审查和最终分析。
  • 共涉及11,491例患者病例。

主要发现

  • 同行评审项目导致加权平均10.8%的放疗计划被修改。
  • 5项研究区分了重大和轻微修改,报道的加权平均修改率分别为1.8%和7.3%。
  • 最常见的修改与靶区勾画相关,占修改计划的45.2%。
  • 剂量处方或书面医嘱相关修改占24.4%。
  • 非靶区勾画或正常组织保护相关修改占7.5%。

临床怎么用

  • 同行评审可作为放射肿瘤学质量保证的推荐组成部分,需考虑其资源投入。
  • 应关注靶区勾画和剂量处方环节的同行评审,因其为最常见修改类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Peer review is a recommended component of quality assurance in radiation oncology; however, it is resource-intensive and its effect on patient care is not well understood. We conducted a systematic review of the published data to assess the reported clinical impact of peer review on radiation treatment plans. METHODS AND MATERIALS: A systematic review of published English studies was performed in accordance with the PRISMA guidelines using the MEDLINE and EMBASE databases and abstracts published from major radiation oncology scientific meeting proceedings. For inclusion, the studies were required to report the effect of peer review on ≥1 element of treatment planning (eg, target volume or organ-at-risk delineation, dose prescription or dosimetry). RESULTS: The initial search strategy identified 882 potentially eligible studies, with 11 meeting the inclusion criteria for full-text review and final analysis. Across a total of 11,491 patient cases, peer review programs led to modifications in a weighted mean of 10.8% of radiation treatment plans. Five studies differentiated between major and minor changes and reported weighted mean rates of change of 1.8% and 7.3%, respectively. The most common changes were related to target volume delineation (45.2% of changed plans), dose prescription or written directives (24.4%), and non-target volume delineation or normal tissue sparing (7.5%). CONCLUSIONS: Our findings suggest that peer review leads to changes in clinical care in approximately 1 of every 9 cases overall. This is similar to the reported rates of change in peer review studies from other oncology-related specialties, such as radiology and pathology.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Brunskill K, Nguyen TK, Boldt RG, et al. Does Peer Review of Radiation Plans Affect Clinical Care? A Systematic Review of the Literature. Int J Radiat Oncol Biol Phys. 2016. PMID: 27816360. doi:10.1016/j.ijrobp.2016.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。